Kentucky System Launches Specialty Pharmacy in 3 Clinics

Why It Matters

Integrating specialty pharmacy services directly into clinic workflows improves patient outcomes and reduces administrative costs, giving Med Center Health a competitive edge in a rapidly growing market.

Key Takeaways

• Med Center Health partners with ClearWay Health to launch specialty pharmacy.
• Neurology, Heart & Lung, and Gastroenterology clinics receive embedded pharmacists.
• Program handles prior authorizations, financial assistance, and benefits investigations.
• Expansion plans include additional clinics and a dedicated pharmacy space.

Pulse Analysis

The U.S. specialty pharmacy market has exploded over the past decade, now exceeding $150 billion in annual sales as biologics and gene therapies become standard for chronic conditions. Payers and providers alike struggle with the high cost, complex administration, and intensive monitoring these drugs require. Embedding pharmacy expertise directly within clinical teams has emerged as a solution, allowing real‑time medication management, adherence support, and rapid navigation of insurance barriers. This model not only improves patient outcomes but also curtails wasteful spending by reducing errors and hospital readmissions.

Med Center Health, a regional system based in Bowling Green, Kentucky, has taken the model a step further by partnering with Boston‑based ClearWay Health to launch a specialty pharmacy program across three of its flagship clinics—Neurology, Western Kentucky Heart & Lung, and Gastroenterology. Certified pharmacists and dedicated patient liaisons sit alongside physicians, flagging eligible patients, coordinating prior authorizations, and securing financial assistance. By shouldering these administrative tasks, the program frees clinicians to focus on diagnosis and treatment, while patients receive faster, more affordable access to high‑cost therapies.

The initiative positions Med Center Health as an early adopter of integrated specialty care in the Midwest, a differentiator that could attract referrals and payer contracts. As the program scales to additional sites and a stand‑alone pharmacy space, the system stands to capture a larger share of specialty drug revenue and improve its risk‑adjusted margins. Moreover, the embedded pharmacy framework dovetails with emerging digital health tools—such as AI‑driven prior‑auth automation and telepharmacy platforms—setting the stage for a more resilient, patient‑centric revenue cycle.